Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 15 | 9 | −6 |
| Shares | 350.2K | 20.8K | −329.4K (−94.1%) |
| Value | $175.5K | $96.4K | −$79.1K (−45.1%) |
New holders (2)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 20 | $93 | 0.00% |
| O'Dell Group, LLC | 1 | $5 | 0.00% |
Sold out (8)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Geode Capital Management, LLC | 124,224 | $62.1K |
| Virtu Financial LLC | 51,832 | $26.0K |
| Two Sigma Securities, LLC | 27,581 | $13.8K |
| State Street Corp | 25,467 | $12.7K |
| Susquehanna International Group, LLP | 21,366 | $10.7K |
| Northern Trust Corp | 17,060 | $8.53K |
| Bank of America Corp | 1,075 | $538 |
| FMR LLC | 915 | $458 |